| Hyperprogressors after immunotherapy: analysis of genomic alterations associated with accelerated growth rate S Kato, A Goodman, V Walavalkar, DA Barkauskas, A Sharabi, ... Clinical Cancer Research 23 (15), 4242-4250, 2017 | 868 | 2017 |
| Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy AB Sharabi, M Lim, TL DeWeese, CG Drake The lancet oncology 16 (13), e498-e509, 2015 | 819 | 2015 |
| Stereotactic radiation therapy augments antigen-specific PD-1–mediated antitumor immune responses via cross-presentation of tumor antigen AB Sharabi, CJ Nirschl, CM Kochel, TR Nirschl, BJ Francica, E Velarde, ... Cancer immunology research 3 (4), 345-355, 2015 | 628 | 2015 |
| Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblasts M Bilban, N Ghaffari-Tabrizi, E Hintermann, S Bauer, S Molzer, C Zoratti, ... Journal of cell science 117 (8), 1319-1328, 2004 | 509 | 2004 |
| Elective nodal irradiation attenuates the combinatorial efficacy of stereotactic radiation therapy and immunotherapy AE Marciscano, A Ghasemzadeh, TR Nirschl, D Theodros, CM Kochel, ... Clinical Cancer Research 24 (20), 5058-5071, 2018 | 244 | 2018 |
| Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy S Kato, KH Kim, HJ Lim, A Boichard, M Nikanjam, E Weihe, DJ Kuo, ... Nature communications 11 (1), 4965, 2020 | 218 | 2020 |
| Tumor immunology and cancer immunotherapy: summary of the 2013 SITC primer RR Raval, AB Sharabi, AJ Walker, CG Drake, P Sharma Journal for immunotherapy of cancer 2, 1-11, 2014 | 175 | 2014 |
| Membrane-type matrix metalloproteinase-1 (MT1-MMP) is a processing enzyme for human laminin γ2 chain N Koshikawa, T Minegishi, A Sharabi, V Quaranta, M Seiki Journal of biological chemistry 280 (1), 88-93, 2005 | 155 | 2005 |
| Inhibitory role of α6β4-associated erbB-2 and phosphoinositide 3-kinase in keratinocyte haptotactic migration dependent on α3β1 integrin E Hintermann, M Bilban, A Sharabi, V Quaranta The Journal of cell biology 153 (3), 465-478, 2001 | 143 | 2001 |
| B cells improve overall survival in HPV-associated squamous cell carcinomas and are activated by radiation and PD-1 blockade SS Kim, S Shen, S Miyauchi, PD Sanders, I Franiak-Pietryga, L Mell, ... Clinical Cancer Research 26 (13), 3345-3359, 2020 | 141 | 2020 |
| Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4 Z Wang, VH Wu, MM Allevato, M Gilardi, Y He, J Luis Callejas-Valera, ... Nature communications 10 (1), 5546, 2019 | 132 | 2019 |
| Matrix metalloproteinases process the laminin-5 γ2-chain and regulate epithelial cell migration E Pirilä, A Sharabi, T Salo, V Quaranta, H Tu, R Heljasvaara, ... Biochemical and biophysical research communications 303 (4), 1012-1017, 2003 | 131 | 2003 |
| Immune modulation of head and neck squamous cell carcinoma and the tumor microenvironment by conventional therapeutics S Miyauchi, SS Kim, J Pang, KA Gold, JS Gutkind, JA Califano, LK Mell, ... Clinical Cancer Research 25 (14), 4211-4223, 2019 | 114 | 2019 |
| Discrete Proteolysis of Focal Contact and Adherens Junction Components in Porphyromonas gingivalis-Infected Oral Keratinocytes: a Strategy for Cell Adhesion … E Hintermann, SK Haake, U Christen, A Sharabi, V Quaranta Infection and immunity 70 (10), 5846-5856, 2002 | 109 | 2002 |
| Exceptional response to nivolumab and stereotactic body radiation therapy (SBRT) in neuroendocrine cervical carcinoma with high tumor mutational burden: management … A Sharabi, SS Kim, S Kato, PD Sanders, SP Patel, P Sanghvi, E Weihe, ... The Oncologist 22 (6), 631-637, 2017 | 106 | 2017 |
| Proteolytic processing of laminin‐5 by MT1‐MMP in tissues and its effects on epithelial cell morphology N Koshikawa, S Schenk, G Moeckel, A Sharabi, K Miyazaki, H Gardner, ... The FASEB journal 18 (2), 1-22, 2004 | 96 | 2004 |
| Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience … AT Wild, SM Hiniker, DT Chang, PT Tran, MA Khashab, MR Limaye, ... Journal of gastrointestinal oncology 4 (4), 343, 2013 | 89 | 2013 |
| Stereotactic radiotherapy combined with immunotherapy: Augmenting radiation’s role in local and systemic treatment AB Sharabi, PT Tran, M Lim, CG Drake, TL DeWeese Oncology (Williston Park, NY) 29 (5), 331, 2015 | 86 | 2015 |
| Twist-2 controls myeloid lineage development and function AB Sharabi, M Aldrich, D Sosic, EN Olson, AD Friedman, SH Lee, ... PLoS biology 6 (12), e316, 2008 | 80 | 2008 |
| TNFα and radioresistant stromal cells are essential for therapeutic efficacy of cyclic dinucleotide STING agonists in nonimmunogenic tumors BJ Francica, A Ghasemzadeh, AL Desbien, D Theodros, KE Sivick, ... Cancer immunology research 6 (4), 422-433, 2018 | 76 | 2018 |
